Clinical Trial Update: To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for evaluating IAH0968 in combination with CAPEOX in HER2-positive metastatic colorectal cancer (Phase 2/Phase 3). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CAPEOX
• IAH0968 (IAH0968)

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: HER2 Gene Mutation | Phase 2, Phase 3 | Status: UNKNOWN